Figure 1.
Figure 1. The human CD34+ cells acquire a morphologic polarity upon in vitro cultivation. (A-C) Light micrographs of human CD34+ cells freshly isolated from the umbilical cord blood (A) or cultured for 1 day (d1) in serum-free medium in the presence (B) or absence (C) of early acting cytokines as growth factors (GF). (D) The human CD34+ cells were cultured in serum-free medium in the presence of early acting cytokines and PI3K inhibitor Ly294002 (Ly). All panels are shown at the same magnification. Note, CD34+ cells that were cultured for 1 day in the presence of early acting cytokines (B) increase in size and acquire a polarized cell shape forming a leading edge at the front (arrowheads) and a uropod at the rear pole (arrows). Even in the absence of early acting cytokines, CD34+ cells can acquire a polarized cell shape, although they do not increase in size (C). The cell polarization and the growth process are inhibited by the PI3K inhibitor (D).

The human CD34+ cells acquire a morphologic polarity upon in vitro cultivation. (A-C) Light micrographs of human CD34+ cells freshly isolated from the umbilical cord blood (A) or cultured for 1 day (d1) in serum-free medium in the presence (B) or absence (C) of early acting cytokines as growth factors (GF). (D) The human CD34+ cells were cultured in serum-free medium in the presence of early acting cytokines and PI3K inhibitor Ly294002 (Ly). All panels are shown at the same magnification. Note, CD34+ cells that were cultured for 1 day in the presence of early acting cytokines (B) increase in size and acquire a polarized cell shape forming a leading edge at the front (arrowheads) and a uropod at the rear pole (arrows). Even in the absence of early acting cytokines, CD34+ cells can acquire a polarized cell shape, although they do not increase in size (C). The cell polarization and the growth process are inhibited by the PI3K inhibitor (D).

Close Modal

or Create an Account

Close Modal
Close Modal